Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,007 | 61,394 | 76,201 | 77,960 | 52,756 |
| Marketable Securities | 14,432 | 9,823 | 4,873 | N/A | 7,998 |
| Receivables | 31,290 | 31,164 | 40,350 | 28,030 | 33,987 |
| Inventories | 7,631 | 3,891 | 4,526 | 5,452 | 6,665 |
| Other current assets | 573 | 449 | 2,429 | 4,110 | 4,291 |
| TOTAL | $118,552 | $111,753 | $134,281 | $122,353 | $114,280 |
| Non-Current Assets | |||||
| PPE Net | 977 | 1,019 | 1,146 | 1,282 | 1,435 |
| Intangibles | 65,740 | 68,175 | 70,610 | 60,114 | 62,118 |
| Other Non-Current Assets | 15,225 | 15,310 | 16,022 | 15,021 | 15,818 |
| TOTAL | $81,942 | $84,504 | $87,778 | $76,417 | $79,371 |
| Total Assets | $200,494 | $196,257 | $222,059 | $198,770 | $193,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,332 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,795 | 8,589 | 6,440 | 14,927 | 9,841 |
| Accrued Expenses | 35,496 | 34,135 | 65,534 | 39,691 | 41,297 |
| Other current liabilities | 1,204 | 1,167 | 1,370 | 1,381 | 1,856 |
| TOTAL | $60,287 | $48,188 | $77,484 | $59,987 | $56,834 |
| Non-Current Liabilities | |||||
| Long Term Debt | 87,622 | 98,623 | 98,307 | 97,994 | 97,682 |
| Other Non-Current Liabilities | 22,186 | 23,599 | 24,660 | 18,634 | 19,397 |
| TOTAL | $109,808 | $122,222 | $122,967 | $116,628 | $117,079 |
| Total Liabilities | $170,095 | $170,410 | $200,451 | $176,615 | $173,913 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,510 | 46,707 | 46,641 | 45,640 | 45,556 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,363,228 | -1,365,354 | -1,366,755 | -1,361,149 | -1,360,789 |
| Other shareholders' equity | -6 | 0 | 0 | 0 | 0 |
| TOTAL | $30,399 | $25,847 | $21,608 | $22,155 | $19,738 |
| Total Liabilities And Equity | $200,494 | $196,257 | $222,059 | $198,770 | $193,651 |